| Q1 FY27 | Jul 31, 2026 | 889 | +0.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY26 | Apr 30, 2026 | 835 | +8.9% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY26 | Jan 31, 2026 | 736 | -9.4% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY26 | Oct 31, 2025 | 823 | +1.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY26 | Jul 31, 2025 | 882 | +11.2% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY25 | Apr 30, 2025 | 767 | +2.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY25 | Jan 31, 2025 | 812 | +4.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY25 | Oct 31, 2024 | 814 | -13.5% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY25 | Jul 31, 2024 | 793 | -4.2% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY24 | Apr 30, 2024 | 750 | -7.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY24 | Jan 31, 2024 | 780 | +2.6% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY24 | Oct 31, 2023 | 941 | +13.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY24 | Jul 31, 2023 | 828 | 0.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY23 | Apr 30, 2023 | 813 | +8.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY23 | Jan 31, 2023 | 760 | -5.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY23 | Oct 31, 2022 | 832 | +6.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY23 | Jul 31, 2022 | 828 | +18.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY22 | Apr 30, 2022 | 751 | -2.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY22 | Jan 31, 2022 | 807 | +14.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY22 | Oct 31, 2021 | 784 | +9.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY22 | Jul 31, 2021 | 700 | 0.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY21 | Apr 30, 2021 | 769 | +0.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY21 | Jan 31, 2021 | 707 | -7.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY21 | Oct 31, 2020 | 717 | -3.4% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY21 | Jul 31, 2020 | 700 | -5.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY20 | Apr 30, 2020 | 767 | +12.6% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY20 | Jan 31, 2020 | 761 | -1.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY20 | Oct 31, 2019 | 742 | +3.9% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY20 | Jul 31, 2019 | 737 | -3.4% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY19 | Apr 30, 2019 | 681 | -16.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY19 | Jan 31, 2019 | 769 | -3.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY19 | Oct 31, 2018 | 714 | -11.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY19 | Jul 31, 2018 | 763 | -8.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY18 | Apr 30, 2018 | 812 | +5.3% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY18 | Jan 31, 2018 | 794 | +8.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY18 | Oct 31, 2017 | 809 | +7.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY18 | Jul 31, 2017 | 837 | +17.2% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY17 | Apr 30, 2017 | 771 | +3.2% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY17 | Jan 31, 2017 | 735 | +2.7% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY17 | Oct 31, 2016 | 751 | +1.2% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY17 | Jul 31, 2016 | 714 | -9.2% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY16 | Apr 30, 2016 | 747 | +1.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY16 | Jan 31, 2016 | 716 | -14.1% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY16 | Oct 31, 2015 | 742 | -3.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY16 | Jul 31, 2015 | 786 | -4.0% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY15 | Apr 30, 2015 | 734 | -7.2% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY15 | Jan 31, 2015 | 834 | +220.8% | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q2 FY15 | Oct 31, 2014 | 771 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q1 FY15 | Jul 31, 2014 | 819 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q4 FY14 | Apr 30, 2014 | 791 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|
| Q3 FY14 | Jan 31, 2014 | 260 | – | U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE ↗ |
|---|